http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101446066-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 |
| filingDate | 2012-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101446066-B1 |
| titleOfInvention | Oral capsule composition for sustained release containing guanfacine |
| abstract | The present invention relates to a composition comprising 2% by weight of guanaxanthin, 60 to 68% by weight of lactose as a diluent, 13 to 17% by weight of hydroxypropylmethyl cellulose as a neutral water swellable release controlling polymer, 13 to 17% by weight of an anionic water- By weight of a disintegrant, 2 to 4% by weight of croscarmellose sodium as a disintegrant, and 0.8 to 1.2% by weight of magnesium stearate as a lubricant. |
| priorityDate | 2012-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.